Candesartan, the angiotensin II receptor blocker, attenuates KChIP2 downregulation in dilated cardiomyopathy and is involved in preventing severe electrical remodeling in inherited dilated cardiomyopathy [183]. The gene discussed is KCNIP2; the disease is dilated cardiomyopathy.